Dr Derek Smith, MD | |
5955 Zeamer Ave, Jber, AK 99506-3702 | |
(907) 580-0103 | |
Not Available |
Full Name | Dr Derek Smith |
---|---|
Gender | Male |
Speciality | Allergy & Immunology |
Location | 5955 Zeamer Ave, Jber, Alaska |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346561941 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | S6742 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Derek Smith, MD 5955 Zeamer Ave, Jber, AK 99506-3702 Ph: (907) 580-0103 | Dr Derek Smith, MD 5955 Zeamer Ave, Jber, AK 99506-3702 Ph: (907) 580-0103 |
News Archive
Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK's proprietary M72 antigen and AS01E adjuvant.
In a new evidence-based paper, the American College of Physicians (ACP) analyzes health care in the United States and 12 other industrialized countries and identifies lessons that could be applied to the particular political and social culture of the United States to achieve a high performing health care system, including achieving universal health insurance coverage for all Americans.
The team led by Manel Esteller, director of the Cancer Epigenetics and Biology Program in the Bellvitge Biomedical Research Institute (IDIBELL), Professor of Genetics at the University of Barcelona and ICREA researcher, has identified epigenetic changes that occur in adult stem cells to generate different body tissues. The finding is published this week in The American Journal of Pathology.
An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis.
A commonly prescribed antidepressant can reduce production of the main ingredient in Alzheimer's brain plaques, according to new research at Washington University School of Medicine in St. Louis and the University of Pennsylvania.
› Verified 6 days ago